Creating software to help match cancer patients with the right treatments using RNA sequencing data
Official title: Developing entrepreneurial skills for the BIOCLIN software platform to support biomarker clinical trials
Funded at Vindhya Data Science INC. · NIH-11237431 · Data updated 2026-11-12
This study is creating a helpful software called BIOCLIN that uses genetic information from cancer patients to find the best treatments for them, especially immunotherapy, so that everyone can get the most effective care based on their individual genes.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vindhya Data Science INC. NIH-funded |
| Lab location | 1 site (Morrisville, United States) |
| Project start | March 1, 2025 |
| Project end | June 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $54,992 |
| NIH project number | 3R43TR005143-01S1 |
| Project ID | NIH-11237431 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients who are being considered for immunotherapy and have undergone RNA sequencing.
✕Less likely to help
Patients who do not have access to RNA sequencing or are not eligible for immunotherapy may not benefit from this research.
What this research studies
This research focuses on developing a software platform called BIOCLIN that utilizes RNA sequencing data to improve the matching of cancer patients to effective treatments. By analyzing genomic biomarkers, the software aims to enhance the predictive power for therapies, particularly immunotherapy, which has shown variable responses in patients. The project addresses key challenges in the clinical application of RNA sequencing, including bioinformatics analysis and regulatory validation, to ensure that patients receive the most appropriate therapies based on their unique genetic profiles.
Why it matters
Potential benefit: If successful, this research could lead to more accurate treatment matching for cancer patients, potentially improving their outcomes and quality of life.
How similar studies have gone: Other research has shown promising results in using RNA sequencing for patient matching in clinical trials, indicating that this approach has potential for success.
Where this research is happening
-
Vindhya Data Science INC.
Morrisville, United States Active
Researchers
- Principal investigator: Reddy, Anupama — Vindhya Data Science INC.
- Study coordinator: Reddy, Anupama
Related research
Other NIH-funded projects on the same topics.
-
Better matching cancer patients to their best treatments
This project is developing a new software tool to help doctors choose the most effective cancer treatments, especially immunotherapies, for patients based on their unique genetic information.
-
A platform to match cancer patients with the best treatments using RNA sequencing.
This study is working on a new tool called BIOCLIN that uses special tests to look at your genes and help doctors find the best cancer treatments for you, especially when it comes to immunotherapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.